Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
02/2005
02/08/2005US6852346 Improving rheological properties and quality of bread, alimentary paste products, noodles; strength and stability
02/08/2005US6852322 Surface proteins of Leptospira
02/08/2005US6852317 Metabolite from streptomyces strain NRRL accession No. B-30145 and mutants thereof for controlling plant diseases
02/08/2005CA2323726C Control of gene expression
02/08/2005CA2323450C Assay of igfbp complex
02/08/2005CA2180103C Gene encoding adseverin
02/08/2005CA2150928C Expression system for producing apolipoprotein ai-m
02/08/2005CA2116914C Novel plasmid for production of crm protein and diphtheria toxin
02/03/2005WO2005010794A2 Method for determining metabolic flux affecting substance production
02/03/2005WO2005010196A1 Method for producing dipeptides
02/03/2005WO2005010182A1 Coryneform bacterium transformant and process for producing dicarboxylic acid using the same
02/03/2005WO2005010175A1 Method for producing l-lysine or l-threonine using escherichia bacteria having attnuated malic enzyme activity
02/03/2005WO2005010171A1 Novel candida tropicalis cj-fid(kctc 10457bp) and manufacturing method of xylitol thereby
02/03/2005WO2005010170A2 Fermentation medium based on a highly hydrolized protein substrate
02/03/2005WO2005010169A2 High throughput or capillary-based screening for a bioactivity or biomolecule
02/03/2005WO2005010165A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
02/03/2005WO2005010156A2 Genes encoding carotenoid compounds
02/03/2005WO2005010144A2 Displacing a plasmid in a bacterial population
02/03/2005WO2005010052A2 Enhanced steep-water
02/03/2005WO2005010050A1 Hetero type pentamer recombinant vaccine
02/03/2005WO2005010036A1 Vaccine and compositions for the prevention and treatment of neisserial infections
02/03/2005WO2005010031A1 Peptides capable of binding to titanium, silver and silicone
02/03/2005WO2005009581A2 Methods and apparatus for blood separation and analysis using membranes on an optical bio-disc
02/03/2005WO2005009463A2 Antigen-presenting cell vaccines and methods of use thereof
02/03/2005WO2005009366A2 Restoring vascular function
02/03/2005WO2005009360A2 Compositions related to a novel endophytic fungi and methods of use
02/03/2005WO2005009345A2 2-desmethyl ansamycin compounds
02/03/2005WO2005009141A2 Oxygenated beverage-containing container
02/03/2005WO2005009115A2 Compositions and methods for the production of betaine lipids
02/03/2005WO2004101449A3 Method of degrading tbp using a photosynthetic bacterial strain
02/03/2005WO2004099408A8 Novel protein and dna coding for the same
02/03/2005WO2004081175A3 Methods and compositions for purification of nucleic acid from a host cell
02/03/2005WO2003094859A3 Epha2 monoclonal antibodies and methods of use thereof
02/03/2005WO2003090515A3 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation
02/03/2005WO2003081250A8 Novel compositions and methods in cancer associated with altered expression of prlr
02/03/2005WO2003066665A3 Proteolytic fermenter
02/03/2005WO2002102235A3 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
02/03/2005WO2002099119A3 B7-related nucleic acids and polypeptides useful for immunomodulation
02/03/2005WO2001048228A8 Methods and materials relating to gene expression
02/03/2005WO2001025401A3 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins
02/03/2005US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides
02/03/2005US20050027113 Compositions and methods relating to the daptomycin biosynthetic gene cluster
02/03/2005US20050027108 Expression vector comprising nucleotide sequences coding cardiovascular system associated protein kinases for use in identifying modulators to treat and prevent cardiovascular and cell proliferative disorders
02/03/2005US20050027104 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease
02/03/2005US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders
02/03/2005US20050026894 2-Desmethyl ansamycin compounds
02/03/2005US20050026837 Novel proteins and methods for producing the proteins
02/03/2005US20050026804 Proteolytic enzyme for use in detergents, laundering; transformed nucleic acid
02/03/2005US20050026293 Autonomously replicating biomolecule for use as gene transfer tool in genetic engineering
02/03/2005US20050026286 Methods and compositions for selective RNAi mediated inhibition of gene expression in mammal cells
02/03/2005US20050026280 Arabidopsis thaliana mutant for use as plant model for monitoring light absorption and photosynthesis in plants
02/03/2005US20050026278 RNA interference mediating small RNA molecules
02/03/2005US20050026269 Novel alkaline protease variants and detergents and cleaning agents containing said novel alkaline protease variants
02/03/2005US20050026268 Phytase from Bacillus subtilis, gene encoding said phytase, method for its production and use
02/03/2005US20050026265 Enhanced sarcosine oxidase for use in measurement of creatinine concentration in human serum or urine; diagnosing renal disorders
02/03/2005US20050026262 Sonication-enhanced digestion process
02/03/2005US20050026259 biosynthesis of (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid using mutant strain of gramnegative bacteria, comprising culturing in agar and ammonium acetate; reuse of acetic acid; efficiency
02/03/2005US20050026258 Mutant N-acetylglutamate synthase and method for L-arginine production
02/03/2005US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders
02/03/2005US20050026247 Using trangenic escherichia to generate bone morphogenic protein for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
02/03/2005US20050026244 Recombinant narbonolide polyketide synthase
02/03/2005US20050026236 PDE 10 cell-based assay and sequences
02/03/2005US20050026233 Using bioassay for loss-of-function mutations in protein kinase (LKB1) as diagnostic tool in detection of cell proliferative disorders; AMP-activated protein kinase (AMPK) and treatment of diabetic, cardiovascular and dietetic disorders
02/03/2005US20050026232 Monoclonal antibody which preferentially binds leukocyte common antigen-related molecule phosphatase (LAR) for use in diagnosis, prevention and treatment of cell proliferative disorders
02/03/2005US20050026230 Method and apparatus for cell recovery
02/03/2005US20050026226 Serum Paraoxonase
02/03/2005US20050026218 Expression vector comprising nucleotide sequences coding type IV secretion system proteins (T4SS) for use in identifying modulator for treatment of rickettsia infection
02/03/2005US20050026177 Preparing pharmaceutical grade plasmids for use as gene transfer tools in genetic engineering
02/03/2005US20050026162 Compositions and methods for the modification of gene expression
02/03/2005US20050025787 Transformed bacteria producing CS6 antigens as vaccines
02/03/2005US20050025749 Grafting heart tissue; closure of heart defect
02/03/2005DE10332623A1 Zellen und Verfahren zur fermentativen Herstellung von R-alpha-Liponsäure Cells and methods for the fermentative preparation of R-alpha-lipoic acid
02/03/2005DE10324926B3 Vorrichtung zur Behandlung eines lebende Zellen enthaltenden biologischen Materials mit einem durch eine Gasentladung erzeugten Plasma An apparatus for treating a biological material containing living cells with a plasma generated by a gas discharge
02/03/2005CA2536644A1 Antibodies and uses thereof
02/03/2005CA2532360A1 Compositions related to a novel endophytic fungi and methods of use
02/03/2005CA2530085A1 Compositions and methods for the production of betaine lipids
02/03/2005CA2527557A1 Genes encoding carotenoid compounds
02/03/2005CA2526814A1 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
02/02/2005EP1502952A2 Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus
02/02/2005EP1502948A1 Ammonia-oxidizing bacteria
02/02/2005EP1502947A1 Use of proteins from whey for the production of microorganisms
02/02/2005EP1502920A2 Cell surface molecule mediating cell adhesion and signal transmission
02/02/2005EP1501947A2 Method of creating a library of bacterial clones with varying levels of gene expression
02/02/2005EP1501936A2 Cytokine protein family
02/02/2005EP1501935A2 Low-cost production of peptides
02/02/2005EP1501928A1 Assay for melanogenesis
02/02/2005EP1501923A2 Pak5-related compositions and methods
02/02/2005EP1501866A2 Apo-2 ligand variants and uses thereof
02/02/2005EP1501857A2 Novel pancortin-pablo protein interactions and methods of use thereof
02/02/2005EP1501855A2 Novel compositions and methods in cancer
02/02/2005EP1501544A2 Alcam and alcam modulators
02/02/2005EP1280812B1 Cyclipostins, a method for their production and the use of the same
02/02/2005EP1268824B1 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use
02/02/2005EP1242601B1 Trichoderma reesei xylanase
02/02/2005EP1141238B1 Production of proteins
02/02/2005EP1092040B1 Methods of inhibiting helicobacter pylori
02/02/2005EP1078074B1 Mutant lactobacillus bulgaricus strains free from beta-galactoside activity
02/02/2005EP1032683B1 Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same
02/02/2005EP0917563B1 Micro-organism which can desulphurise benzothiophenes
02/02/2005EP0826031B1 Ataxia-telangiectasia gene and its genomic organization